Ron Struthers: The Juniors Are Forging the Path Forward
Source: Kevin Michael Grace of The Gold Report  (3/5/14)
Is the bear market in mining equities finally over? It looks that way, says Ron Struthers, publisher and editor of Struthers' Resource Stock Report. In this interview with The Gold Report, Struthers explains what distinguishes this recovery from past ones: TSX Venture Exchange stocks, not the majors, are leading the way. But which juniors should investors favor? Struthers names several with proven management, ample funding and good share structures. More >

Kiril Mugerman: Graphite Investors Should Look for Large Flakes, Small Resources
Source: Kevin Michael Grace of The Mining Report  (3/4/14)
Companies that boast 80,000 ton-per-year production or high purity levels don't always impress Kiril Mugerman, mining analyst with Industrial Alliance Securities. Why? Because finding buyers for all those tons is a huge challenge, and thrifty end-users like to purify lower-grade graphite in-house. In this interview with The Mining Report, Mugerman explains why he looks for smaller projects that can hit revenue targets, and indicates which of the 176 graphite projects out there are worth your attention. More >

Uranium Hot Spots: Mauritania, Gabon and Zambia
Source: Uranium Investing News  (3/4/14)
"These countries have potential that has attracted many companies, from juniors to established multinationals." More >

Michael Ballanger: Junior Miners Rise from the Ashes
Source: Brian Sylvester of The Gold Report  (3/3/14)
You didn't really think that junior miners would languish forever, did you? Junior mining stocks are starting to make a careful climb from the depths after tax-loss selling in December. But some investors, beaten down as badly as mining stocks, are still hesitant. For those investors, Michael Ballanger, director of wealth management and a certified investment manager with Richardson GMP, has a win-win strategy. In this interview with The Gold Report, Ballanger talks about his investment ideas for 2014 and a less risky twist on the balanced portfolio. More >

Evaluate Biotech Stocks with Cynicism: Debjit Chattopadhyay
Source: George S. Mack of The Life Sciences Report  (2/27/14)
Biotech investing is a risky business, so investors should thoroughly examine a company's vital statistics before taking the plunge. That's the recommendation of Managing Director Debjit Chattopadhyay of Emerging Growth Equities, who brings a strict scientific discipline to stock analysis. As a former medical researcher, Chattopadhyay comes by his skepticism honestly, and in this interview with The Life Sciences Report, he brings five exciting—but critically scrutinized—growth names to investors' attention. More >

Bryan Brokmeier Remains Bullish on Life Sciences Tools and Diagnostics Companies
Source: George S. Mack of The Life Sciences Report  (2/27/14)
This will be a great year for life sciences tools and diagnostics companies, says Bryan Brokmeier of Maxim Group. And no, growth won't be driven by irrational exuberance, the senior analyst explains in this interview with The Life Sciences Report. Instead, the industry is bolstered by powerful tailwinds fanning new demand for molecular diagnostics, and by the clamoring of academia, pharmas and biotechs for specialized assay platforms. As Brokmeier lays out his sector growth theory, he also highlights a group of stocks with value drivers that could power a portfolio with biotechlike growth potential. More >

A Pair of Top Picks, a Risky Pair and an Ace in the Hole: Justin Anderson Shows His Hand
Source: Tom Armistead of The Energy Report  (2/27/14)
Since its inception in 2007, the Salman Partners' Top Pick Index has made a 251% return. The index is a huge pot for investors in the international oil and gas space to bet on, but it's not for the untutored. Salman Partners Analyst Justin Anderson walked The Energy Report through the risks and returns of the game. Find out how he plays his hand. More >

Michael Fowler: How to Find Wildflowers in the Weeds
Source: Brian Sylvester of The Gold Report  (2/26/14)
Michael Fowler, senior mining analyst with Loewen Ondaatje McCutcheon Ltd. in Toronto, doesn't typically focus on midtier gold companies, but the opportunities are just too good to pass up. In this interview with The Gold Report, Fowler tells us that even private equity is getting into the game and discusses a handful of companies that are good growth plays.
More >

Gold: The Most Sought-After Metal on Earth
Source: Visual Capitalist  (2/26/14)
How did gold become the most sought-after metal on earth? Visual Capitalist has some answers. More >

Paul Renken: For 2014 Gains, Look to Uranium, PGMs and Gems
Source: Brian Sylvester of The Mining Report  (2/25/14)
Paul Renken, senior geologist and analyst with VSA Capital, calls 2014 a soft year for gold and silver prices, but foresees stronger prices—and demand—for nickel, copper and tech metals as the year progresses. In this Mining Report interview, he lists the three commodities investors should feel good about and digs into the details of the Indonesian ban on exports of raw ore. More >

Pharma Learns to Brave the Patent Cliff
Source: EP Vantage   (2/25/14)
"The pharmaceutical industry is on the brink of another significant patent expiry cliff. Unlike the one it fell off in 2012, though, the latest version will leave it relatively unscathed." More >

Specialty Pharma Bulking Up: $100B Boost in 2013 Market Cap Drives Deals in Early 2014
Source: Andrew Forman, EY  (2/25/14)
"Specialty pharma acquirers accounted for roughly 40% of all 2013 M&A by value, with no fewer than seven offshore deals totaling over US$35B. All of these deals resulted in increased 2014 guidance." More >

Benjamin Asuncion and Geordie Mark: Six Gold and Silver Leaders at Today's Prices
Source: Kevin Michael Grace of The Gold Report  (2/24/14)
Benjamin Asuncion and Geordie Mark of Haywood Securities forecast 2014 gold and silver prices of $1,300/ounce and $21.50/ounce, respectively. In this interview with The Gold Report, they argue that the gold and silver companies that will thrive in 2014 will be those blessed with prudent but aggressive management that can post good margins at today's prices. And they suggest a half-dozen gold and silver miners poised to do just that. More >

Size Does Matter in Rare Earth Mining: Christopher Ecclestone
Source: Vivien Diniz, Resource Investing News  (2/24/14)
"It looks like market watchers have started to get a handle on what makes a good rare earth company." More >

Chen Lin's Perfect Biotech Market Prescription: Buy Low, Sell High!
Source: Peter Byrne of The Life Sciences Report  (2/20/14)
Charming and smart, Chen Lin makes a lot of money by jumping in and out of the highly volatile biotech market while obeying a set of simple rules, which he reveals in this interview with The Life Sciences Report. Applying his strong science background, Lin zeros in on biotech firms with solid products. The trick is in having the guts to buy low and sell high, against the market tide, says the editor of the widely respected newsletter, What is Chen Buying? What is Chen Selling? Lin also brings us up to date on his favorite picks. More >

Catalysts Drive These Stocks: Mara Goldstein
Source: George S. Mack of The Life Sciences Report  (2/20/14)
Whether biotech stocks keep up the scorching pace of 2013 remains to be seen, but we can count on one thing going forward, says Cantor Fitzgerald Senior Analyst Mara Goldstein. We are still in a catalyst-driven market. In this interview with The Life Sciences Report, Goldstein discusses four names with approaching milestones that she believes are important growth drivers. Her fifth pick is a binary event story, meaning it could skyrocket on good data or plummet on bad. More >

Uranium Supply Disruptions Spell Opportunity for Investors: David Talbot
Source: Tom Armistead of The Energy Report  (2/20/14)
A supply crisis is looming in the uranium industry, and today's uranium price, stagnant at an eight-year low, will shoot up quickly when restarts of Japanese nuclear power plants bring back demand with a vengeance, David Talbot tells The Energy Report. Talbot, a geologist and senior mining analyst at Dundee Capital Markets, is excited about the potential of Canada's Athabasca Basin, the world's most prolific uranium source. But beyond the pounds in the ground, he sees money to be made in undervalued companies. More >

Supply and Demand Key to Base Metals Success: Adam Low
Source: Kevin Michael Grace of The Gold Report  (2/19/14)
Adam Low of Raymond James believes that the outlook is excellent for zinc, good for copper and neutral for iron ore. In this interview with The Gold Report, he argues that it comes down to supply and demand. Copper supply may soon lag demand, and zinc demand, which is increasing steadily, will soon face a 10% decline in supply. Low suggests eight miners that should benefit from providing the metals the global economy will need to support future growth. More >

How to Vet Graphite Investments: Stephen Riddle
Source: Brian Sylvester of The Mining Report  (2/18/14)
Stephen Riddle, CEO of Asbury Graphite Mills Inc., has been in the business long enough to have seen companies come and go, sometimes more than once. He brings a realist's perspective to this Mining Report interview, and explains the questions he asks himself, as an investor, at each stage of mine development. He also comments on the supply-and-demand picture, and names the characteristics of his ideal graphite mine. More >

The Most Important Question Top Stock Pickers Keith Schaefer, Eric Coffin and Lawrence Roulston Ask Company Presidents
Source: JT Long of The Mining Report  (2/18/14)
Payback time? Fallback plan? Money in the bank? What would you ask the CEO of a company you were considering investing in? In advance of the Prospectors and Developers Association of Canada convention in March, newsletter writers Keith Schaefer, Eric Coffin and Lawrence Roulston are bringing 15 energy and mining companies together for a "meet the management" Subscriber Investment Summit in Toronto. In this interview with The Mining Report, the experts share their sometimes surprising responses to the state of the industry. More >

This "Workhorse" Metal Is Ready for a Breakout
Source: Peter Krauth, Money Morning  (2/18/14)
"Demand's rising. Supply's down. Zinc prices, and profits, are about to take off." More >

'Mexico Mike' Kachanovsky: How to Buy Prime Rib Companies at Hamburger Prices
Source: Brian Sylvester of The Gold Report  (2/17/14)
You scan the menu and notice that the prime rib and the hamburger are the same price. What do you order? The precious metals market isn't so different, according to "Mexico Mike" Kachanovsky, consultant to hedge funds and mining companies and contributor to SmartInvestment.ca. The market has pulverized the price of top-notch mining stocks to the same level as the struggling names. So, which would you buy? In this interview with The Gold Report, Kachanovsky reveals how to find the prime rib of the gold market. More >

Christian Versus Embry: Gold, Lies and Video Interviews
Source: Lawrence Williams, Mineweb  (2/17/14)
"Strongly opposing views on the likely speed of any gold price increase, and some of the factors affecting this likelihood, make for some very polarized opinions." More >

Big Pharma Continues the Race for Electroporation
Source: Brian Nichols, Wall St. Cheat Sheet  (2/17/14)
"Electroporation is a delivery platform that uses an electrical pulse to create temporary pores in cells." More >

Big Pharma Will Find Good Hunting Among Early-Stage Biotechs: Dhesh Govender
Source: Tracy Salcedo-Chourré of The Life Sciences Report  (2/13/14)
Dhesh Govender, manager of the life sciences portfolio for Cedar Lane Enterprises Inc., has the inside track when it comes to identifying the hottest biotech trends. In this interview with The Life Sciences Report, Govender explains why he thinks plenty of upside remains in the life sciences sector, and reveals trade secrets that every investor should consider when building a successful investment strategy. More >